WebYamaguchi, Motoko ; Tobinai, Kensei ; Oguchi, Masahiko et al. / Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma : An updated analysis of the Japan Clinical Oncology Group Study JCOG0211. In: Journal of Clinical Oncology. 2012 ; Vol. 30, No. 32. pp. 4044-4046. WebNK/T-cell lymphoma (NKTCL) in Japan • Incidence: 1.0 - 2.6% of ML • Median age at diagnosis: 58 years Lymphoma Study Group of Japanese Pathologists.
Phase I/II Study of Concurrent Chemoradiotherapy for
Web8 ott 2012 · In the November 20, 2009, issue of Journal of Clinical Oncology, we reported the results of our first analysis of a phase I/II study of concurrent chemoradiotherapy for newly diagnosed localized nasal NKTCL (Japan Clinical Oncology Group study JCOG0211). 3 Our first analysis demonstrated improved overall survival (OS) and progression-free … Web10 nov 2012 · Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211 J … tafe cert 3 horticulture
NK/T-cell lymphoma: the role of asparaginase Japanese experience
Web– JCOG0211 (PI/II) – Concurrent chemoradiotherapy (RT-2/3DeVIC) • Newly-diagnosed stage IV, relapsed/refractory NKTCL – NKTSG (Multinational trials in East Asia) – SMILE-P1 & P2 – SMILE chemotherapy Yamaguchi M, Tobinai K, Oguchi M, et al. J Clin Oncol 2009, 2012 (correspondence) Yamaguchi M, Kwong YL, Kim WS, et al. J Clin Oncol 2011 Web10 mag 2010 · Concurrent chemoradiotherapy for limited-stage extranodal natural killer/t-cell lymphoma, nasal type WebPhase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Ohshima K, Matsuno Y, Terauchi T, Nawano S, Ishikura S, Kagami Y, … tafe cert 3 hairdressing